The Form 144 filing by a founding venture investor, combined with heavy insider selling over the past month, suggests potential continued distribution. Monitor for subsequent Form 4 filings to confirm actual sales, and watch for any operational updates or clinical data that could offset the negative signal.
Price Chart
Executive Summary
Atlas Venture Opportunity Fund I, L.P., a major venture capital backer of Dyne Therapeutics, filed a Form 144 notice of intent to sell 47,103 shares of common stock, with an approximate market value of $849,738 based on the filing date. This represents a relatively small portion of the fund's holdings and the company's $3.0B market cap, but the sale comes amid heavy recent insider selling ($13.2M over 30 days) and may signal a gradual exit by a founding investor.
Key Facts
- Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 47,103 shares of DYN common stock.
- Estimated aggregate market value of the proposed sale is $849,738.12.
- The shares were acquired in a private placement on August 7, 2020.
- Over the past 30 days, there have been 10 insider sells totaling $13.2M.
- The company has a market cap of approximately $3.0B.
- The filing date is April 28, 2026.
Financial Impact
Proposed sale of ~$850K in stock, representing a small fraction of the company's $3.0B market cap.
Risk Factors
- Continued insider selling could pressure the stock price.
- The sale by a prominent early investor may signal reduced confidence in near-term prospects.
- Heavy insider selling cluster may precede negative news or a downturn.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-027983 |
| Document: 0001628280-26-027983-index.html | 0001628280-26-027983 |
| Document: 0001628280-26-027983.txt | 0001628280-26-027983 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access